247 related articles for article (PubMed ID: 29240674)
1. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674
[TBL] [Abstract][Full Text] [Related]
2. Flavonolignans inhibit the arachidonic acid pathway in blood platelets.
Bijak M; Saluk-Bijak J
BMC Complement Altern Med; 2017 Aug; 17(1):396. PubMed ID: 28797264
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388
[TBL] [Abstract][Full Text] [Related]
4. Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes.
Bijak M; Dziedzic A; Synowiec E; Sliwinski T; Saluk-Bijak J
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28914761
[TBL] [Abstract][Full Text] [Related]
5. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
6. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
[TBL] [Abstract][Full Text] [Related]
7. Chemotaxonomic and biosynthetic relationships between flavonolignans produced by Silybum marianum populations.
AbouZid SF; Ahmed HS; Moawad AS; Owis AI; Chen SN; Nachtergael A; McAlpine JB; Brent Friesen J; Pauli GF
Fitoterapia; 2017 Jun; 119():175-184. PubMed ID: 28392269
[TBL] [Abstract][Full Text] [Related]
8. Silybin and its congeners: from traditional medicine to molecular effects.
Křen V; Valentová K
Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
[TBL] [Abstract][Full Text] [Related]
9. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
[TBL] [Abstract][Full Text] [Related]
10. Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood.
Bijak M; Szelenberger R; Saluk J; Nowak P
Int J Biol Macromol; 2017 Feb; 95():682-688. PubMed ID: 27923566
[TBL] [Abstract][Full Text] [Related]
11. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
Chlopcíková S; Psotová J; Miketová P; Simánek V
Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
[TBL] [Abstract][Full Text] [Related]
12. Flavonolignans reduce the response of blood platelet to collagen.
Bijak M; Dziedzic A; Saluk-Bijak J
Int J Biol Macromol; 2018 Jan; 106():878-884. PubMed ID: 28842200
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
14. [Flavonolignans - compounds not only for liver treatment].
Bijak M
Pol Merkur Lekarski; 2017 Jan; 42(247):34-37. PubMed ID: 28134230
[TBL] [Abstract][Full Text] [Related]
15. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom.
Poppe L; Petersen M
Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292
[TBL] [Abstract][Full Text] [Related]
16. Skin Protective Activity of Silymarin and its Flavonolignans.
Vostálová J; Tinková E; Biedermann D; Kosina P; Ulrichová J; Rajnochová Svobodová A
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875758
[No Abstract] [Full Text] [Related]
17. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
18. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans.
Vrba J; Papoušková B; Lněničková K; Kosina P; Křen V; Ulrichová J
J Pharm Biomed Anal; 2020 Jan; 178():112972. PubMed ID: 31727359
[TBL] [Abstract][Full Text] [Related]
19. Supercritical CO₂ extraction of oil, fatty acids and flavonolignans from milk thistle seeds: Evaluation of their antioxidant and cytotoxic activities in Caco-2 cells.
Ben Rahal N; Barba FJ; Barth D; Chevalot I
Food Chem Toxicol; 2015 Sep; 83():275-82. PubMed ID: 26172510
[TBL] [Abstract][Full Text] [Related]
20. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
Soleimani V; Delghandi PS; Moallem SA; Karimi G
Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
